Mode
Text Size
Log in / Sign up
N/A N=25 Randomized Double-blind Treatment

Multifocal Contact Lenses Fitting Methods Comparison

Presbyopia

Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: Overall Vision Satisfaction — 78.6; 83.5 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Control Lenses (control fitting approach) (Device); Test Lenses (test fitting approach) (Device)
Age
Adult, Older Adult · 40+ yrs
Sex
All
Sponsor
CooperVision, Inc.
Primary completion
Dec 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Overall Vision Satisfaction
78.6; 83.5
PRIMARY
Overall Lens Preference
10; 11; 4
SECONDARY
Overall Binocular Visual Acuity Index
0.12; 0.09
SECONDARY
Number of Contact Lenses
1; 1

Summary

The purpose of this study was to compare the clinical performance of two fitting approaches for multifocal contact lenses.

Eligibility Criteria

Inclusion Criteria

  • At least 40 years old;
  • Have read and understood the Participant Information Sheet;
  • Have read, signed and dated the Informed Consent;
  • Best corrected visual acuity of at least 20/25 in each eye;
  • Have normal eyes with the exception of the need for visual correction;
  • Current multifocal contact lens wearer;
  • Spectacle refraction:

Distance: Sphere: -6.00D to + 4.00D Astigmatism: 0.00D to -0.75D Near Addition: Established Presbyopes: +1.50D & +1.75D

  • Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule.

Exclusion Criteria

  • Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
  • Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator;
  • Monocular participants (only one eye with functional vision) or participants fit with only one lens;
  • Any moderate or severe ocular condition observed during the slit-lamp examination at the enrolment visit;
  • History of herpetic keratitis, ocular surgery or irregular cornea;
  • Known pregnancy or lactation during the study period;
  • Enrolment of the investigator or his/her staff, family members of the investigator, family members of the investigator's staff, or individuals living in the households of these individuals.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05734846). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search